- Home
- WAL vs LEGN Comparison
WAL vs LEGN Comparison
Compare WAL & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAL
- LEGN
- Stock Information
- Founded
- WAL 1994
- LEGN 2014
- Country
- WAL United States
- LEGN United States
- Employees
- WAL N/A
- LEGN N/A
- Industry
- WAL Major Banks
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- WAL Finance
- LEGN Health Care
- Exchange
- WAL Nasdaq
- LEGN Nasdaq
- Market Cap
- WAL 7.3B
- LEGN 7.0B
- IPO Year
- WAL 2005
- LEGN 2020
- Fundamental
- Price
- WAL $66.32
- LEGN $32.80
- Analyst Decision
- WAL Strong Buy
- LEGN Strong Buy
- Analyst Count
- WAL 15
- LEGN 12
- Target Price
- WAL $96.40
- LEGN $79.00
- AVG Volume (30 Days)
- WAL 1.5M
- LEGN 1.6M
- Earning Date
- WAL 04-21-2025
- LEGN 05-12-2025
- Dividend Yield
- WAL 2.30%
- LEGN N/A
- EPS Growth
- WAL 8.41
- LEGN N/A
- EPS
- WAL 7.09
- LEGN N/A
- Revenue
- WAL $3,016,200,000.00
- LEGN $627,241,000.00
- Revenue This Year
- WAL $13.39
- LEGN $66.92
- Revenue Next Year
- WAL $9.74
- LEGN $51.77
- P/E Ratio
- WAL $9.35
- LEGN N/A
- Revenue Growth
- WAL 17.96
- LEGN 119.97
- 52 Week Low
- WAL $53.75
- LEGN $29.27
- 52 Week High
- WAL $98.10
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- WAL 41.59
- LEGN 45.92
- Support Level
- WAL $60.01
- LEGN $29.27
- Resistance Level
- WAL $67.00
- LEGN $35.11
- Average True Range (ATR)
- WAL 4.79
- LEGN 1.89
- MACD
- WAL 0.09
- LEGN 0.16
- Stochastic Oscillator
- WAL 44.83
- LEGN 60.48
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.